Total Valuation
Fresenius Medical Care AG & Co. KGaA has a market cap or net worth of CHF10.07B. The enterprise value is CHF21.51K.
Market CapCHF10.07B
Enterprise ValueCHF21.51K
Share Statistics
Fresenius Medical Care AG & Co. KGaA has 268,564,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding268,564,640
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Fresenius Medical Care AG & Co. KGaA’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.34%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.34%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee183.05K
Profits Per Employee9.12K
Employee Count107,226
Asset Turnover0.63
Inventory Turnover6.82
Valuation Ratios
The current PE Ratio of Fresenius Medical Care AG & Co. KGaA is 12.2. Fresenius Medical Care AG & Co. KGaA’s PEG ratio is 0.15.
PE Ratio12.2
PS Ratio0.60
PB Ratio0.89
Price to Fair Value0.89
Price to FCF6.72
Price to Operating Cash Flow3.83
PEG Ratio0.15
Income Statement
In the last 12 months, Fresenius Medical Care AG & Co. KGaA had revenue of 19.63B and earned 978.00M in profits. Earnings per share was 3.36.
Revenue19.63B
Gross Profit5.03B
Operating Income1.83B
Pretax Income1.51B
Net Income978.00M
EBITDA3.34B
Earnings Per Share (EPS)3.36
Cash Flow
In the last 12 months, operating cash flow was 2.83B and capital expenditures -1.05B, giving a free cash flow of 1.78B billion.
Operating Cash Flow2.83B
Free Cash Flow1.78B
Free Cash Flow per Share6.65
Dividends & Yields
Fresenius Medical Care AG & Co. KGaA pays an annual dividend of CHF1.39, resulting in a dividend yield of 3.6%
Dividend Per ShareCHF1.39
Dividend Yield3.6%
Payout Ratio38.37%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.17
52-Week Price Change-49.62%
50-Day Moving Average38.67
200-Day Moving Average42.09
Relative Strength Index (RSI)39.68
Average Volume (3m)0.00
Important Dates
Fresenius Medical Care AG & Co. KGaA upcoming earnings date is Nov 3, 2026, TBA (Confirmed).
Last Earnings DateAug 3, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
Fresenius Medical Care AG & Co. KGaA as a current ratio of 1.26, with Debt / Equity ratio of 87.31%
Current Ratio1.26
Quick Ratio0.92
Debt to Market Cap0.62
Net Debt to EBITDA2.76
Interest Coverage Ratio4.74
Taxes
In the past 12 months, Fresenius Medical Care AG & Co. KGaA has paid 321.00M in taxes.
Income Tax321.00M
Effective Tax Rate0.21
Enterprise Valuation
Fresenius Medical Care AG & Co. KGaA EV to EBITDA ratio is 6.31, with an EV/FCF ratio of 11.93.
EV to Sales1.07
EV to EBITDA6.31
EV to Free Cash Flow11.93
EV to Operating Cash Flow7.86
Balance Sheet
Fresenius Medical Care AG & Co. KGaA has CHF1.45B in cash and marketable securities with CHF10.96B in debt, giving a net cash position of -CHF9.51B billion.
Cash & Marketable SecuritiesCHF1.45B
Total DebtCHF10.96B
Net Cash-CHF9.51B
Net Cash Per Share-CHF35.43
Tangible Book Value Per Share-CHF1.86
Margins
Gross margin is 26.36%, with operating margin of 9.31%, and net profit margin of 4.98%.
Gross Margin26.36%
Operating Margin9.31%
Pretax Margin7.70%
Net Profit Margin4.98%
EBITDA Margin17.01%
EBIT Margin9.66%
Analyst Forecast
The average price target for Fresenius Medical Care AG & Co. KGaA is CHF35.18, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetCHF35.18
Price Target Upside-3.04% Downside
Analyst ConsensusModerate Sell
Analyst Count11
Revenue Growth Forecast-2.28%
EPS Growth Forecast45.97%